Abstract
The prevalence of microalbuminuria and arterial hypertension among type 1 (insulin-dependent) diabetic patients is poorly known in Italy. In the preliminary phase of a large outpatient screening programme, we addressed the possibility of using non-time urine samples to predit the chance of detecting albumin excretion rate (AER) in the range of microalbuminuria. We therefore measured urinary albumin and creatinine concentration in timed overnight collections from 641 type 1 diabetic patients with serum creatinine levels lower than 133 μmol/l. AER was strongly and comparably predicted both by urinary albumin concentration (UAlb;r 2=0.754) and by the urinary albumin to creatinine concentration ratio (A/C;r 2=0.773). After exploring several independent cut-off levels for UAlb and A/C, AER in the range 20–200 μg/min (n=91) was found to be predicted with 90% sensitivity and specificity either by UAlb≧20 mg/l or by A/C≧2.0 mg/mmol. UAlb was negatively associated with diuresis, and false negative outcomes were explained by polyuria when screening by this variable. A/C was positively associated with female gender among normoalbuminuric patients, in line with the lower urinary excretion of creatinine in women (7.2±0.25 vs 10.2±0.35 μmol/min,P<0.00001). A significant excess of false positive outcomes in women compared with men was found when screening by any A/C cut-off level equal to or less than 2.5 mg/mmol. Simplified screening techniques seem to remain, however, a practicable option for the detection of microalbuminuria both in epidemiology and in clinical practice.
Similar content being viewed by others
References
Viberti GC, Hill RD, Jarrett RJ, Argyropuolos A, Mahmud U, Keen H, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I:1430–1432, 1982
Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T, Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 26:406–410, 1984
Mogensen CE, Christensen CK, Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93, 1984
Parving H-H, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR, Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 100:550–555, 1982
Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P, Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297:1092–1095, 1988
Cohen D, Dodds R, Viberti GC, Effect of protein restriction in insulin-dependent diabetics at risk of nephropathy. BMJ 294:795–798, 1987
Christensen CK, Mogensen CE, The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 2:97–102, 1985
Mathiesen ER, Hommel E, Giese J, Parving H-H, Efficacy of captopril in postponing nephropathy in normotensive insulin dependent patients with microalbuminuria. BMJ 303:81–87, 1991
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T, Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164–170, 1991
Krans HMJ, Prota M, Keen H, Diabetes care and research in Europe: the St. Vincent Declaration action programme. Implementation document. G Ital Diabetol 12 [Suppl 2]:22–26, 1992
Microalbuminuria Collaborative Study Group, Microalbuminuria in type 1 diabetic patients: prevalence and clinical characteristics. Diabetes Care 15:495–501, 1992
Nørgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Sælan H, Deckert T, Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:407–410, 1990
Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E, Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. BMJ 296:156–160, 1988
Gatling W, Knight C, Mullee MA, Hill RD, Microalbuminuria in diabetes: a population study of the prevalence and assessment of three screening tests. Diabetic Med 5:343–347, 1988
Mogensen CE, Chachati A, Christensen CK, Close ER, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC, Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9:85–95, 1985
Gatling W, Knight C, Hill RD, Screening for early diabetic nephropathy: which sample to detect microalbuminuria? Diabetic Med 2:451–455, 1985
Cowell CT, Rogers S, Silink M, First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes. Diabetologia 29:97–99, 1986
Viberti GC, Vergani D, Detection of potentially reversible diabetic albuminuria: a three-drop agglutination test for urinary albumin at low concentration. Diabetes 31:973–975, 1982
Cohen DL, Close CF, Viberti GC, The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabetic Med 4:437–440, 1987
Eshøj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF, Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabetic Med 4:531–533, 1987
Hutchinson AS, O'Reilly DStJ, MacCuish AC, Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 34:2019–2021, 1988
Nathan DM, Rosenbaum C, Protasowicki D, Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10:414–418, 1987
Marshall SM, Screening for microalbuminuria: which measurement? Diabetic Med 8:706–711, 1991
Coonrad BA, Ellis D, Becker DJ, Dorman JS, Drash AL, Kuller LH, Orchard TJ, Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy. Diabetes Care 12:389–393, 1989
Linton AS, Rowe DJF, Ames' Microbumintes evaluated, and its correlation with total protein and albumin concentration in urine. Clin Chem 34:1927–1928, 1988
Kouri TT, Viikari JSA, Mattila KS, Irjala KMA, Microalbuminuria: invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients. Diabetes Care 14:591–593, 1991
Ginsberg JM, Chang BS, Matarese RA, Garella S, Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543–1546, 1983
“Todd-Sanford” Clinical diagnosis by laboratory methods, 15th edn. Saunders, Philadelphia, 1974
Watts GF, Morris RW, Khan K, Polak A, Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin Chim Acta 172:191–198, 1988
Chachati A, Frenckell R von, Foidart-Willems J, Godon JP, Lefèbvre PJ, Variability of albumin excretion in insulin-dependent diabetics. Diabetic Med 4:441–445, 1987
Jerums G, Cooper ME, Seeman E, Murray RML, McNeil JJ, Spectrum of proteinuria in type I and type II diabetes. Diabetes Care 10:419–427, 1987
Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW, Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38:1602–1610, 1989
Mogensen CE, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356–360, 1984
Nelson RG, for the Diabetic Renal Disease Study Group, Renal function in non-insulin-dependent diabetes mellitus: purposes and design of the Diabetic Renal Disease Study. Acta Diabetol 28:143–150, 1991
Author information
Authors and Affiliations
Additional information
See Appendix
Rights and permissions
About this article
Cite this article
Mangili, R., Deferrari, G., Di Mario, U. et al. Prevalence of hypertension and microalbuminuria in adult type 1 (insulin-dependent) diabetic patients without renal failure in Italy. I. Validation of screening techniques to detect microalbuminuria. Acta Diabetol 29, 156–166 (1992). https://doi.org/10.1007/BF00573481
Issue Date:
DOI: https://doi.org/10.1007/BF00573481